biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > JD, do you own any other stocks other than bioaf?

<< Previous

Bullboard Posts

Next >>

Comment by greaterfoolFredon Apr 26, 2022 12:01pm

93 Views

Post# 34632377

RE:RE:RE:RE:JD, do you own any other stocks other than bioaf?

Careful POF, this narcissist stuff is what got you banned the last time. But then again, perhaps JD doesn't have as much influence over Stockhouse as he used to have.
Turning to Bioasis, have patience folks, I am 80% confident that things will work out in our favour. We just have to make it past the monkeys and then the emerald city will soon come into view.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China